Explore plasma proteomics innovations tackling the dynamic range challenge, revealing biomarkers and advancing personalized ...

Agency drug reviewers had questioned patient risk criteria and the efficacy endpoint used in a key trial supporting J&J's ...

Paraneoplastic syndrome represents a major systemic complication in cancer patients but its causes remain unclear. This study ...

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...

Bats are known as natural hosts for highly pathogenic viruses such as MERS- and SARS-related coronaviruses, as well as the ...

Detailed price information for Pliant Therapeutics Inc (PLRX-Q) from The Globe and Mail including charting and trades.

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood, ...